Volume 2 • Issue 1 • 2011
Review Article
Hormones and receptors in endometrial cancer
David Bender, Thomas Buekers and Kimberly Leslie
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–25
Wnt/ß-catenin/Lef-1 signaling in the uterus and its implications in uterine gland formation and cancer development
Dawne N. Shelton and Michael J. Goodheart
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–11
Article
Toward a microRNA signature of endometrial cancer
Eric J. Devor, Michael J. Goodheart and Kimberly K. Leslie
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–7
Case Report
Positron emission tomography in detection of metastatic leiomyosarcoma in a postoperative patient: a case report
David B Engle, Linda M. Smiley, Scott L. Baum and Greg P. Wellman
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–5
Diagnosis of endometrial cancer complicated by morbid obesity—a case report
Janna Girardi and Michael Goodheart
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–5
Board Member Spotlight
Abstract
The relationship between vascularity, p53 gene mutations and distant metastatic disease in epithelial ovarian carcinoma
Janna Girardi, Megan Samuelson, Anna Button, Koen De Geest, David P. Bender, Amina Ahmed and Michael Goodheart
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–2
Lymphoid Enhancing Factor 1 (Lef-1) overexpression in epithelial ovarian, fallopian tube and peritoneal cancer and associations with clinical factors
Aine Clements, David Engle, Dawne Shelton, Traci Neff, Soo Park, David Bender, Amina Ahmed, Koen De Geest, Anna Button, John F. Engelhardt and Michael Goodheart
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–2
Combination therapy with mTOR and PI3 kinase inhibitors is broadly synergistic in a wide variety of endometrial cancer cells
Shujie Yang, Xue Xiao, Xiangbing Meng and Kimberly K. Leslie
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–2
Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer
David Engle, Hubert Fornalik, Traci Neff, Anna Button, K Collins, Amina Ahmed, David Bender, Susan Lutgendorf and Michael Goodheart
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–2
Zmiz1 is overexpressed in epithelial ovarian cancer and associated with p53 gene mutations
Niyati J Nadkarni, Laura M. Rogers, Megan Samuelson, Traci Neff, David P. Bender, Amina Ahmed, Koen De Geest, Anna Button, Adam Dupuy and Michael Goodheart
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–2
MiR-888: A newly identified miRNA significantly over-expressed in endometrial cancers
Adriann M. Hovey, Eric J. Devor and Kimberly K. Leslie
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–1
Knockdown of MTDH increases drug sensitivity to HDAC inhibitor and TRAIL combination treatment in endometrial cancer cells
Xiangbing Meng, Pavla Brachova, Shujie Yang, Zhi Xiong, Yuping Zhang and Kimberly K. Leslie
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–2
H19/miR-675 non-coding RNA expression differentiates among cancers of the human endometrium.
Eric J Devor, Jill N. DeMik, Brandon M. Schickling, Michael J. Goodheart and Kimberly K. Leslie
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–1
The combination of Paclitaxel and Gefitinib inhibits endometrial cancer cells by inducing mitotic catastrophe: proof of principle for dual therapy in endometrial cancer
Xiangbing Meng, Laura L. Laidler, Lina Albitar, Anna M. Holmes, Donghai Dai, Thomas E. Buekers, David P. Bender and Kimberly K. Leslie
2011-07-28 Volume 2 • Issue 1 • 2011 • 1–2